We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Hypersegmented Neutrophils Associated with Reduced Lung Function

By LabMedica International staff writers
Posted on 19 Feb 2019
Neutrophils are phagocytic innate immune cells, which patrol the blood vessels and become activated in response to inflammatory triggers. More...
Activation results in neutrophil migration to the site of infection, where pathogens can be eliminated by phagocytosis or NETosis.

Inflammation characterized by airway neutrophilia is reported in many cases of chronic obstructive airway disease. This includes 20% to 30% cases of asthma, more than 40% cases of chronic obstructive pulmonary disease (COPD), and 70% cases of non-cystic fibrosis (CF) bronchiectasis.

Scientists at the University of Newcastle (Callaghan, Australia) and their associates recruited adults who were undergoing bronchoscopy either for medical purposes or were undergoing a surgical procedure that involved endotracheal intubation and had spirometry results. Participants included 78 adults with obstructive airway disease comprised of 39 with stable asthma, 20 with COPD and 19 diagnosed as bronchiectasis and 20 healthy controls.

Spirometry was performed using an Easy One Spirometer. Flexible bronchoscopy was performed and a fraction of the bronchial lavage (BL) was sent for microbial detection while the rest was processed. The BL was centrifuged and the cell pellet was resuspended in phosphate buffered saline to the concentration of 1×106/mL and cellular cytospins were prepared. The cytospins were stained with May-Grünwald Giemsa and a differential cell count of 400 non-squamous cells was performed.

The team reported that the numbers of hypersegmented neutrophils were significantly elevated in participants with airway disease compared with healthy controls. Both the number and the proportion of hypersegmented neutrophils were highest in COPD participants (median (Q1–Q3) of 1,073.6 (258.8–2,742) × 102/mL and 24.5 (14.0–46.5) %, respectively). An increased proportion of hypersegmented neutrophils in airway disease participants was significantly associated with lower forced expiratory volume in 1 s/forced vital capacity percent. In participants with COPD, the proportion of hypersegmented neutrophils was positively associated with proportion of eosinophils and negatively associated with cell viability.

The authors concluded that the presence of three morphologically different subsets of neutrophils in the airways of healthy and obstructive airway disease participants, that is, asthma, COPD and bronchiectasis. The increased proportion of hypersegmented neutrophils in the airways of obstructive airway disease participants was associated with reduced lung function of these participants. The proportion of hypersegmented neutrophils was highest in COPD participants in comparison to all other groups. The study was published on January 28, 2019, in the journal BMJ OPEN.

Related Links:
University of Newcastle


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.